Mpox vaccine is safe and generates a robust antibody response in adolescents
10/16/2024 10:15 AM EDT
NIH clinical trial addresses knowledge gap on vaccine use in adolescent populations
| This email was sent to politikimx@gmail.com using GovDelivery Communications Cloud on behalf of: National Institutes of Health (NIH) · 9000 Rockville Pike · Bethesda MD 20892 · 301-496-4000 / TTY 301-402-9612 |